Today, Moderna sells just two products: its Covid vaccine called Spikevax — a rival to Comirnaty from Pfizer and BioNTech, ...

Moderna said it is suing Pfizer and its German partner BioNTech for patent infringement linked to the development of the first Covid-19 vaccines. The US biotech company is alleging that mRNA ...

A new vaccine that protects against Covid-19 is nearly 95% effective, early data from US company Moderna shows. The results come hot on the heels of similar results from Pfizer, and add to growing ...

Moderna's mRESVIA joined the market after RSV vaccines from Pfizer and GSK already had established themselves. At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $ ...

Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent dispute centring on their mRNA-based vaccines for COVID-19. Moderna fired the first volley back in August ...

For Pfizer's and Moderna's two-shot vaccines, the second shot amplifies an existing immune response, so people typically feel more run-down after that dose. Vaccines prompt our bodies to produce ...

Covid vaccines from companies like Pfizer, Moderna and AstraZeneca were linked ... (COVID-19), so getting vaccinated is still ...

US pharmaceutical company Moderna Friday sued Pfizer / BioNTech over patent ownership infringement regarding the COVID-19 RNA vaccine “Moderna is convinced that Pfizer and BioNTech's Comirnaty ...

Top vaccine stocks for investors to consider include Pfizer and Moderna. Other vaccine stocks to watch include Bavarian Nordic and Emergent BioSolutions. Key findings are powered by ChatGPT and ...

The Moderna and Pfizer agreements include options for a total of 600 million doses, 300 million apiece, but these can only be exercised with additional funding from Congress, according to HHS.